Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1979 1
1985 1
1987 1
1990 2
1991 2
1993 1
1994 2
1996 2
1997 1
1998 1
1999 1
2000 4
2001 1
2002 4
2003 1
2004 1
2005 1
2006 5
2007 2
2008 6
2009 6
2010 3
2011 1
2012 4
2013 5
2014 5
2015 3
2016 6
2017 11
2018 10
2019 8
2020 10
2021 8
2022 5
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Results by year

Filters applied: . Clear all
Proximity search should include two or more words. Proximity operator ignored :~0
Page 1
Classification and Differential Diagnosis of Diabetic Nephropathy.
Qi C, Mao X, Zhang Z, Wu H. Qi C, et al. J Diabetes Res. 2017;2017:8637138. doi: 10.1155/2017/8637138. Epub 2017 Feb 20. J Diabetes Res. 2017. PMID: 28316995 Free PMC article. Review.
Applications and evaluations using Tervaert classification and indications for renal biopsy are summarized in this review according to recent studies. Meanwhile, differential diagnosis with another nodular glomerulopathy and the situation that a typical DN superimposed wit …
Applications and evaluations using Tervaert classification and indications for renal biopsy are summarized in this review according to recen …
C3 Glomerulopathy: Pathogenesis and Treatment.
Ahmad SB, Bomback AS. Ahmad SB, et al. Adv Chronic Kidney Dis. 2020 Mar;27(2):104-110. doi: 10.1053/j.ackd.2019.12.003. Adv Chronic Kidney Dis. 2020. PMID: 32553242 Review.
C3 glomerulopathy (C3G) is a rare set of kidney diseases with 2 patterns: C3 glomerulonephritis (C3GN) and dense deposit disease. ...
C3 glomerulopathy (C3G) is a rare set of kidney diseases with 2 patterns: C3 glomerulonephritis (C3GN) and dense deposit disease. ...
C3G and Ig-MPGN-treatment standard.
Noris M, Remuzzi G. Noris M, et al. Nephrol Dial Transplant. 2024 Jan 31;39(2):202-214. doi: 10.1093/ndt/gfad182. Nephrol Dial Transplant. 2024. PMID: 37604793 Free PMC article. Review.
Among the broad spectrum of membranoproliferative glomerulonephritis (MPGN), immunofluorescence distinguishes C3 glomerulopathy (C3G), with predominant C3 deposits, and immunoglobulin-associated MPGN (Ig-MPGN), with combined C3 and Ig. ...This approach may facilitate accur …
Among the broad spectrum of membranoproliferative glomerulonephritis (MPGN), immunofluorescence distinguishes C3 glomerulopathy (C3G) …
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.
Leung N, Bridoux F, Batuman V, Chaidos A, Cockwell P, D'Agati VD, Dispenzieri A, Fervenza FC, Fermand JP, Gibbs S, Gillmore JD, Herrera GA, Jaccard A, Jevremovic D, Kastritis E, Kukreti V, Kyle RA, Lachmann HJ, Larsen CP, Ludwig H, Markowitz GS, Merlini G, Mollee P, Picken MM, Rajkumar VS, Royal V, Sanders PW, Sethi S, Venner CP, Voorhees PM, Wechalekar AD, Weiss BM, Nasr SH. Leung N, et al. Nat Rev Nephrol. 2019 Jan;15(1):45-59. doi: 10.1038/s41581-018-0077-4. Nat Rev Nephrol. 2019. PMID: 30510265 Free PMC article.
The diagnosis of MGRS-related disease is established by kidney biopsy and immunofluorescence studies to identify the monotypic immunoglobulin deposits (although these deposits are minimal in patients with either C3 glomerulopathy or thrombotic microangiopathy). Accordingly …
The diagnosis of MGRS-related disease is established by kidney biopsy and immunofluorescence studies to identify the monotypic immunoglobuli …
Practical management of C3 glomerulopathy and Ig-mediated MPGN: facts and uncertainties.
Fakhouri F, Le Quintrec M, Frémeaux-Bacchi V. Fakhouri F, et al. Kidney Int. 2020 Nov;98(5):1135-1148. doi: 10.1016/j.kint.2020.05.053. Epub 2020 Jul 3. Kidney Int. 2020. PMID: 32622830 Review.
In recent years, a substantial body of experimental and clinical work has been devoted to C3 glomerulopathy and Ig-mediated membranoproliferative glomerulonephritis. ...They concern their pathophysiology, classification, clinical course, relevance of biomarkers and of path …
In recent years, a substantial body of experimental and clinical work has been devoted to C3 glomerulopathy and Ig-mediated membranop …
Small-molecule factor B inhibitor for the treatment of complement-mediated diseases.
Schubart A, Anderson K, Mainolfi N, Sellner H, Ehara T, Adams CM, Mac Sweeney A, Liao SM, Crowley M, Littlewood-Evans A, Sarret S, Wieczorek G, Perrot L, Dubost V, Flandre T, Zhang Y, Smith RJH, Risitano AM, Karki RG, Zhang C, Valeur E, Sirockin F, Gerhartz B, Erbel P, Hughes N, Smith TM, Cumin F, Argikar UA, Haraldsson B, Mogi M, Sedrani R, Wiesmann C, Jaffee B, Maibaum J, Flohr S, Harrison R, Eder J. Schubart A, et al. Proc Natl Acad Sci U S A. 2019 Apr 16;116(16):7926-7931. doi: 10.1073/pnas.1820892116. Epub 2019 Mar 29. Proc Natl Acad Sci U S A. 2019. PMID: 30926668 Free PMC article.
Oral administration of the inhibitor prevents KRN-induced arthritis in mice and is effective upon prophylactic and therapeutic dosing in an experimental model of membranous nephropathy in rats. In addition, inhibition of factor B prevents complement activation in sera from …
Oral administration of the inhibitor prevents KRN-induced arthritis in mice and is effective upon prophylactic and therapeutic dosing …
Advances in Understanding of Pathogenesis and Treatment of Immune-Mediated Kidney Disease: A Review.
Kant S, Kronbichler A, Sharma P, Geetha D. Kant S, et al. Am J Kidney Dis. 2022 Apr;79(4):582-600. doi: 10.1053/j.ajkd.2021.07.019. Epub 2021 Sep 8. Am J Kidney Dis. 2022. PMID: 34508831 Review.
This progress has culminated in the development of multiple therapeutic agents that have consistently improved renal and patient outcomes. ...New molecular pathways in various disorders of alternate complement pathway are described, which in turn have led to development of …
This progress has culminated in the development of multiple therapeutic agents that have consistently improved renal and patient outc …
Membranoproliferative glomerulonephritis: no longer the same disease and may need very different treatment.
Noris M, Daina E, Remuzzi G. Noris M, et al. Nephrol Dial Transplant. 2023 Feb 13;38(2):283-290. doi: 10.1093/ndt/gfab281. Nephrol Dial Transplant. 2023. PMID: 34596686
Based on immunofluorescence findings, MPGN has been classified into complement-mediated C3 glomerulopathy (C3G) and immune complex-mediated MPGN (IC-MPGN). However, this classification leaves a number of issues unresolved. ...These results provide the groundwork for a more …
Based on immunofluorescence findings, MPGN has been classified into complement-mediated C3 glomerulopathy (C3G) and immune complex-me …
Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN.
Sethi S, Haas M, Markowitz GS, D'Agati VD, Rennke HG, Jennette JC, Bajema IM, Alpers CE, Chang A, Cornell LD, Cosio FG, Fogo AB, Glassock RJ, Hariharan S, Kambham N, Lager DJ, Leung N, Mengel M, Nath KA, Roberts IS, Rovin BH, Seshan SV, Smith RJ, Walker PD, Winearls CG, Appel GB, Alexander MP, Cattran DC, Casado CA, Cook HT, De Vriese AS, Radhakrishnan J, Racusen LC, Ronco P, Fervenza FC. Sethi S, et al. J Am Soc Nephrol. 2016 May;27(5):1278-87. doi: 10.1681/ASN.2015060612. Epub 2015 Nov 13. J Am Soc Nephrol. 2016. PMID: 26567243 Free PMC article.
On the basis of etiology/pathogenesis, GN is classified into the following five pathogenic types, each with specific disease entities: immune-complex GN, pauci-immune GN, antiglomerular basement membrane GN, monoclonal Ig GN, and C3 glomerulopathy. The pathogenesis-based c …
On the basis of etiology/pathogenesis, GN is classified into the following five pathogenic types, each with specific disease entities: immun …
Recurrent Glomerular Disease after Kidney Transplantation: Diagnostic and Management Dilemmas.
Uffing A, Hullekes F, Riella LV, Hogan JJ. Uffing A, et al. Clin J Am Soc Nephrol. 2021 Nov;16(11):1730-1742. doi: 10.2215/CJN.00280121. Epub 2021 Oct 22. Clin J Am Soc Nephrol. 2021. PMID: 34686531 Free PMC article.
Many of the different entities post-transplant still suffer from incomplete knowledge on pathophysiology, and therefore lack targeted and effective therapies. In this review, we focus on specific clinical dilemmas encountered by physicians in managing recurrent glomerular …
Many of the different entities post-transplant still suffer from incomplete knowledge on pathophysiology, and therefore lack targeted and ef …
123 results